home

The mission of the Psychiatric Cell Map Initiative (PCMI) is to bridge the gap between the genome and clinic in the field of neuropsychiatric disorder research by systematically mapping the physical and genetic interaction networks underlying these disorders, including autism spectrum disorders, Tourette disorder, epilepsy, intellectual disability, and schizophrenia. This will form a key resource for precision medicine.